← Open Payments lookup

YEKATERINA TATARCHUK: Open Payments

NPI 1336374412 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$674 in 24 payments from 8 companies in 2025. Trend: 2023 $200 · 2024 $573 · 2025 $674

Food & beverage: $674
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$160
Janssen Pharmaceuticals, Inc4$139
ABBVIE INC.4$104
E.R. Squibb & Sons, L.L.C.3$82
Alkermes, Inc.3$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Teva Pharmaceuticals USA, Inc.2$52
Otsuka America Pharmaceutical, Inc.1$28

Products named: INGREZZA, INVEGA SUSTENNA, VRAYLAR, COBENFY, CAPLYTA, UZEDY, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across PA — which companies pay providers there.